Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Desert Gold Report Results from 3,900 Meter Phase 2 Exploration Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Isis Pharmaceuticals Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patients With Myotonic Dystrophy Type 1

PR Newswire December 16, 2014

NeoGenomics, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, and the Northwestern Medicine Developmental Therapeutics Institute Launch Collaborative Translational Research Program

PR Newswire December 16, 2014

Foundation Medicine to Be Added to NASDAQ Biotechnology Index

Business Wire December 16, 2014

Aerie Pharmaceuticals Added to NASDAQ Biotechnology Index (NBI)

Business Wire December 16, 2014

Cell Therapy Catapult to Create Cutting-Edge Global Manufacturing Site in Stevenage

Business Wire December 16, 2014

Research and Markets: Canada Surgical Sutures Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG

Business Wire December 16, 2014

Applied DNA Sciences' Anti-Theft System Recommended by Sweden Police, Insurance Officials

Marketwired December 16, 2014

Research and Markets: France Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG

Business Wire December 16, 2014

New Covaris Process Enables Accurate, NGS-Grade RNA Extraction from FFPE Tissue Samples

PR Newswire December 16, 2014

Crescendo Biologics' Receives Further Investment from Astellas Venture Management to Develop Novel Humabody(TM) Therapeutics Targeting Immune Checkpoint Inhibitors

PR Newswire December 16, 2014

Novartis gains FDA approval for Signifor® LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder

Thomson Reuters ONE December 16, 2014

Roche launches PCR molecular diagnostic system for point of care environment

PR Newswire December 16, 2014

bluebird bio Announces Pricing of Public Offering of Common Stock

Business Wire December 15, 2014

Find Your Story with AncestryDNA and Trending Today on the Discovery Channel

PR Newswire December 15, 2014

Pfizer Announces Palbociclib PALOMA-1 Data Published in The Lancet Oncology

Business Wire December 15, 2014

Ceres Announces Changes to Board of Directors

PR Newswire December 15, 2014

Prothena Receives FDA Fast Track Designation for NEOD001, a Monoclonal Antibody for the Treatment of Patients With AL Amyloidosis

GlobeNewswire December 15, 2014

NanoString Technologies Highlights Important Results from Prosigna Decision Impact Study Presented at the 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium

Business Wire December 15, 2014

Celldex Announces Completion of Enrollment in Phase 3 Study of Rindopepimut in Frontline Glioblastoma

GlobeNewswire December 15, 2014

bluebird bio Announces Proposed Public Offering of Common Stock

Business Wire December 15, 2014